KATHLEEN TORRENS: Open Payments
NPI 1669075594 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$812 in 26 payments from 12 companies in 2025. Trend: 2023 $355 · 2024 $376 · 2025 $812
Food & beverage: $727Education: $85
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $153 |
| Astellas Pharma US Inc | 1 | $124 |
| SEAGEN INC. | 1 | $85 |
| Lilly USA, LLC | 4 | $84 |
| Daiichi Sankyo Inc. | 3 | $81 |
| Janssen Scientific Affairs, LLC | 2 | $77 |
| Merck Sharp & Dohme LLC | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Gilead Sciences, Inc. | 1 | $34 |
| Janssen Biotech, Inc. | 1 | $26 |
Products named: ENHERTU, Xtandi, VERZENIO, ERLEADA, KISQALI, KEYTRUDA, DATROWAY, DARZALEX.
Industry payments across FL — which companies pay providers there.
